Prestige Consumer Healthcare, Inc. (PBH)
45.26
+0.49
(+1.09%)
USD |
NYSE |
Oct 02, 16:00
45.28
+0.02
(+0.04%)
After-Hours: 20:00
Prestige Consumer Healthcare Price : 45.26 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 44.88 | 45.75 | 44.60 | 45.26 | 543299.0 |
| Oct 01, 2026 | 45.76 | 46.13 | 44.64 | 44.77 | 731385.0 |
| Sep 30, 2026 | 46.69 | 46.69 | 45.85 | 45.87 | 583492.0 |
| Sep 29, 2026 | 46.73 | 46.85 | 46.04 | 46.74 | 566702.0 |
| Sep 28, 2026 | 46.25 | 47.33 | 46.24 | 46.93 | 651764.0 |
| Sep 25, 2026 | 45.34 | 46.72 | 44.97 | 46.61 | 467652.0 |
| Sep 24, 2026 | 46.12 | 46.49 | 45.30 | 45.65 | 627215.0 |
| Sep 23, 2026 | 47.45 | 47.46 | 45.91 | 45.92 | 503990.0 |
| Sep 22, 2026 | 47.55 | 47.80 | 47.02 | 47.73 | 619563.0 |
| Sep 21, 2026 | 45.01 | 47.00 | 44.46 | 46.80 | 660423.0 |
| Sep 18, 2026 | 46.29 | 46.40 | 44.88 | 44.97 | 2.021M |
| Sep 17, 2026 | 47.20 | 47.48 | 45.90 | 46.47 | 504033.0 |
| Sep 16, 2026 | 46.83 | 47.68 | 46.49 | 46.86 | 536930.0 |
| Sep 15, 2026 | 47.22 | 48.25 | 46.38 | 46.68 | 767131.0 |
| Sep 14, 2026 | 47.91 | 48.42 | 47.17 | 47.62 | 580758.0 |
| Sep 11, 2026 | 47.68 | 47.75 | 46.48 | 46.95 | 495641.0 |
| Sep 10, 2026 | 49.37 | 49.51 | 47.29 | 47.34 | 513594.0 |
| Sep 09, 2026 | 49.53 | 49.87 | 48.17 | 48.70 | 474868.0 |
| Sep 08, 2026 | 51.67 | 51.67 | 49.73 | 49.79 | 418334.0 |
| Sep 04, 2026 | 51.80 | 52.58 | 51.80 | 52.26 | 342930.0 |
| Sep 03, 2026 | 53.45 | 53.83 | 51.86 | 52.56 | 449102.0 |
| Sep 02, 2026 | 52.88 | 53.95 | 52.73 | 52.83 | 440013.0 |
| Sep 01, 2026 | 52.50 | 53.57 | 52.28 | 52.64 | 592569.0 |
| Aug 31, 2026 | 51.97 | 52.46 | 51.08 | 51.78 | 472244.0 |
| Aug 28, 2026 | 51.50 | 52.54 | 51.22 | 52.47 | 299807.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Supernus Pharmaceuticals, Inc. | 42.38 |
| Structure Therapeutics, Inc. | 27.67 |
| ANI Pharmaceuticals, Inc. | 72.18 |
| Corcept Therapeutics, Inc. | 116.23 |
| Veru, Inc. | 2.51 |
Price Related Metrics
| PE Ratio | 12.67 |
| PS Ratio | 1.973 |
| Price to Book Value | 1.119 |
| Price to Free Cash Flow | 9.261 |
| Earnings Yield | 7.89% |
| Market Cap | 2.144B |
| Operating PE Ratio | 7.512 |
| Normalized PE Ratio | 12.67 |